| The roles of MicroRNA in lung cancer KL Wu, YM Tsai, CT Lien, PL Kuo, JY Hung International journal of molecular sciences 20 (7), 1611, 2019 | 282 | 2019 |
| Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib KL Wu, MJ Tsai, CJ Yang, WA Chang, JY Hung, CJ Yen, CH Shen, ... Lung Cancer 88 (2), 187-194, 2015 | 83 | 2015 |
| Systematic review and network meta-analysis of anaplastic lymphoma kinase (ALK) inhibitors for treatment-naïve ALK-positive lung cancer CH Chuang, HL Chen, HM Chang, YC Tsai, KL Wu, IH Chen, KC Chen, ... Cancers 13 (8), 1966, 2021 | 51 | 2021 |
| Upregulation of Thr/Tyr kinase increases the cancer progression by neurotensin and dihydropyrimidinase-like 3 in lung cancer YM Tsai, KL Wu, YY Chang, JY Hung, WA Chang, CY Chang, SF Jian, ... International Journal of Molecular Sciences 21 (5), 1640, 2020 | 25 | 2020 |
| Cysteinyl leukotriene pathway and cancer MJ Tsai, WA Chang, CH Chuang, KL Wu, CH Cheng, CC Sheu, YL Hsu, ... International Journal of Molecular Sciences 23 (1), 120, 2022 | 21 | 2022 |
| Systematic review and network meta-analysis of immune checkpoint inhibitors in combination with chemotherapy as a first-line therapy for extensive-stage small cell carcinoma HL Chen, YK Tu, HM Chang, TH Lee, KL Wu, YC Tsai, MH Lee, CJ Yang, ... Cancers 12 (12), 3629, 2020 | 21 | 2020 |
| The Downregulation of LSAMP Expression Promotes Lung Cancer Progression and Is Associated with Poor Survival Prognosis CY Chang, KL Wu, YY Chang, YW Liu, YC Huang, SF Jian, YS Lin, ... Journal of Personalized Medicine 11 (6), 578, 2021 | 19 | 2021 |
| Loss of miR-145-5p causes ceruloplasmin interference with PHD-iron axis and HIF-2α stabilization in lung adenocarcinoma-mediated angiogenesis YM Tsai, KL Wu, YY Chang, WA Chang, YC Huang, SF Jian, PH Tsai, ... International Journal of Molecular Sciences 21 (14), 5081, 2020 | 19 | 2020 |
| The salvage therapy in lung adenocarcinoma initially harbored susceptible EGFR mutation and acquired resistance occurred to the first-line gefitinib and second … CJ Yang, JY Hung, MJ Tsai, KL Wu, TC Liu, SH Chou, JY Lee, JS Hsu, ... BMC Pharmacology and Toxicology 18, 1-9, 2017 | 19 | 2017 |
| miR-150-5p-containing extracellular vesicles are a new immunoregulator that favor the progression of lung cancer in hypoxic microenvironments by altering the phenotype of NK cells WA Chang, MJ Tsai, JY Hung, KL Wu, YM Tsai, YC Huang, CY Chang, ... Cancers 13 (24), 6252, 2021 | 18 | 2021 |
| Cooperation Between Cancer and Fibroblasts in Vascular Mimicry and N2-Type Neutrophil Recruitment via Notch2–Jagged1 Interaction in Lung Cancer YM Tsai, KL Wu, YW Liu, WA Chang, YC Huang, CY Chang, PH Tsai, ... Frontiers in Oncology 11, 696931, 2021 | 18 | 2021 |
| Amine oxidase, copper containing 3 exerts anti‑mesenchymal transformation and enhances CD4+ T‑cell recruitment to prolong survival in lung cancer CY Chang, KL Wu, YY Chang, PH Tsai, JY Hung, WA Chang, SF Jian, ... Oncology reports 46 (3), 1-15, 2021 | 17 | 2021 |
| First-line anaplastic lymphoma kinase (ALK) inhibitors for ALK-positive lung cancer in Asian populations: systematic review and network meta-analysis KL Wu, HL Chen, YM Tsai, TH Lee, HM Chang, YC Tsai, CH Chuang, ... Journal of clinical medicine 10 (19), 4376, 2021 | 14 | 2021 |
| Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic HL Chang, PJ Wei, KL Wu, HL Huang, CJ Yang Lung Cancer 146, 376-377, 2020 | 12 | 2020 |
| CHADS2, CHA2DS2ASc, and New ABCD Scores Predict the Risk of Peripheral Arterial Disease in Patients with Sleep Apnea KL Wu, CY Kuo, YC Tsai, JY Hung, CC Sheu, CJ Yang, CY Hsu, MN Wu, ... Journal of clinical medicine 8 (2), 188, 2019 | 12 | 2019 |
| Dasatinib‐induced chylothorax in a patient with chronic myeloid leukaemia: a case report and literature review CC Hsu, JF Hsu, KL Wu Respirology Case Reports 9 (6), e00753, 2021 | 10 | 2021 |
| Ubiquitin conjugating enzyme E2 H (UBE2H) is linked to poor outcomes and metastasis in lung adenocarcinoma MC Yen, KL Wu, YW Liu, YY Chang, CY Chang, JY Hung, YM Tsai, ... Biology 10 (5), 378, 2021 | 9 | 2021 |
| The therapeutic potential of ADAMTS8 in lung adenocarcinoma without targetable therapy HC Lee, CY Chang, KL Wu, HH Chiang, YY Chang, LX Liu, YC Huang, ... Journal of Personalized Medicine 12 (6), 902, 2022 | 7 | 2022 |
| LINC02323 facilitates development of lung squamous cell carcinoma by miRNA sponge and RBP dysregulation and links to poor prognosis KL Wu, YM Tsai, YC Huang, YY Wu, CY Chang, YW Liu, YL Hsu, JY Hung Thoracic Cancer 14 (4), 407-418, 2023 | 5 | 2023 |
| Characterization of the pleural microenvironment niche and cancer transition using single-cell RNA sequencing in EGFR-mutated lung cancer YY Wu, YL Hsu, YC Huang, YC Su, KL Wu, CY Chang, CT Ong, JC Lai, ... Theranostics 13 (13), 4412, 2023 | 5 | 2023 |
HSU YA LING高雄醫學大學Verificeret mail på kmu.edu.tw
